MBMarvin Bergsneider

Marvin Bergsneider

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Marvin Bergsneider has a total of 346 co-authors. Here are the top co-authors by number of shared publications:

  • Marilene B. Wang

    Department of Head and Neck Surgery, David School of Medicine, University of California, Los Angeles, California, USA

    10 shared publications
  • Paul M. Vespa

    David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA

    7 shared publications
  • Xiao Hu

    Emory University, Atlanta, GA, USA

    7 shared publications
  • Jeffrey D. Suh

    UCLA David Geffen School of Medicine, Los Angeles, California, United States

    6 shared publications
  • Hsiao-Ming Wu

    Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095-7039, USA

    5 shared publications
  • Marilene B. Wang

    Department of Head and Neck Surgery, David Geffen School of Medicine at the University of California, Los Angeles (UCLA) Medical Center, Los Angeles, California, United States

    5 shared publications

Latest Publications

  • Safety and Efficacy of Repeat Surgery for Recurrent Craniopharyngiomas: A RAPID Consortium Collaboration

    by Ryan M. Shih, Maya Harary, Marvin Bergsneider, Marilene Wang, Anthony P. Heaney, Kyle C. Wu, Daniel M. Prevedello, James J. Evans, Michael R. Chicoine, Albert H. Kim, et al.

    BACKGROUND AND OBJECTIVES: Craniopharyngiomas (CPs) recur in 20% to 50% of cases after initial management. To date, there are no large multi-institutional series investigating outcomes in patients receiving surgery for recurrent CP. Here, we leverage the Registry of Adenomas of the Pituitary and Related Disorders to analyze outcomes after surgical treatment of recurrent CP. METHODS: Demographic, clinical, radiographic, surgical, and outcome variables were analyzed for 483 patients receiving surgery for primary or recurrent CP across 16 US-based academic skull-base centers comprising the Registry of Adenomas of the Pituitary and Related Disorders consortium from 2000 to 2024. RESULTS: Among the 483 patients, 360 (74.5%) had primary CP and 123 (25.5%) had recurrent CP. The recurrent cohort was younger at initial diagnosis ( P adj < .01) and recurrence ( P adj = .02). Adamantinomatous CPs were more common in the recurrent cohort but not significantly so, and 33.3% of cases had prior radiation therapy. Recurrent cases had more frequent preoperative endocrine dysfunction and hormone replacement ( P adj < .01). Patients with recurrent CP had less frequent suprasellar tumor extension ( P adj = .04) and more frequent preinfundibular/transinfundibular over retroinfundibular localization ( P adj = .02). There were no differences in operative approach; endoscopic endonasal surgery was the most common, and procedures achieved similar distributions of gross and subtotal resection in both cohorts ( P adj = .30) with similar low frequencies of unplanned reoperation and surgical complications. New postoperative arginine vasopressin deficiency (in patients without preoperative arginine vasopressin deficiency) was more common in the primary cohort ( P adj = .04), but long-term follow-up demonstrated similar frequencies of endocrine dysfunction in both cohorts and comparably low rates (P adj = .17). CONCLUSION: This study provides the largest comparative evaluation of patients undergoing surgery for recurrent vs primary CP. Despite prior treatment, patients with recurrent CP achieved comparable resection outcomes with similar rates of neuroendocrine dysfunction. These findings indicate surgical resection remains a safe and efficacious option for recurrent CP, especially as emerging targeted therapies become available.

  • Disentangling secretory ambiguity and the limitations of classical thresholds in defining prolactinomas

    by Maya Harary, Mishek Thapa, Stuart D. Harper, Ines Donangelo, Anthony P. Heaney, Won Kim, Marvin Bergsneider

  • Open Access

    Reassessing Routine Postoperative Imaging in Acromegaly: Insights from a Cohort with Biochemical Remission

    by Jelena Maletkovic, Marvin Bergsneider, Won Kim, Marilene B. Wang, Jeffrey D. Suh, Michael Linetsky, Noriko Salamon, Sandra Pekic Djurdjevic, Anthony P. Heaney

    Background: Postoperative evaluation for growth hormone-producing pituitary tumors entails assessing remission via biochemical markers alongside MRI to detect residual tumors. While postoperative imaging provides important anatomical information regarding potential residual tumor, it is reasonable to ask if imaging offers largely redundant data when biochemical remission is already established. This study aimed to determine the clinical utility of post-surgical surveillance imaging in patients who achieved biochemical remission with normal age- and sex-matched IGF-1 at ~3 months postoperatively. Furthermore, we sought to evaluate the long-term durability of biochemical control in this patient subset. Methods: We conducted a retrospective analysis on patients who underwent endoscopic endonasal approach surgery for acromegaly and had a minimum of 3 years of follow-up clinical, biochemical and imaging data. Results: In total, 15 of 28 patients (54%) achieved initial biochemical remission and had a 100% sustained remission rate during the follow-up period of 3–14 years, underscoring the importance of surgical radicality for achieving durable remission. Conclusions: Our findings suggest that for patients who achieved biochemical remission following transsphenoidal surgery for acromegaly, routine postoperative imaging provides negligible additional diagnostic information from an endocrinological perspective. As such, we propose that no further postoperative imaging is needed for patients in clinical and biochemical remission. This approach offers a significant reduction in the clinical burden and healthcare costs for patients associated with long-term management of their disease.

  • Open Access

    Development and validation of clinical screening systems for Cushing disease in the United States

    by Jorge E. Salcedo-Sifuentes, Sonal Mehta, Carter M. Suryadevara, Marvin Bergsneider, Kevin C.J. Yuen, Paul A. Gardner, Julie M. Silverstein, Albert H. Kim, James J. Evans, Garni Barkhoudarian, et al.

    Purpose Clinical screening systems (CSSs) for Cushing syndrome (CS) validated in Europe have not been evaluated for CS or Cushing disease (CD) in the United States (US). We aimed to evaluate existing CSSs in US patients and develop two new symptom-based CSSs to identify patients with high pre-test probability of disease warranting referral for definitive biochemical workup—one for broad CS screening and one specifically for CD. Methods Data were obtained from the Registry of Adenomas of the Pituitary and Related Disorders (RAPID)—comprising 615 patients who underwent transnasal transsphenoidal resection for CD at one of 11 US pituitary centers, the Centers for Disease Control and Prevention’s 2019 National Health Interview Survey (NHIS)—comprising 31,997 US respondents, and a single institution CD-NFA cohort—comprising 468 US patients diagnosed with either CD (n = 385) or nonfunctioning adenoma (n = 83). The RAPID Community Cushing CSS was derived from differences between the RAPID and NHIS cohorts, and the RAPID CD CSS from differences between patients with CD versus NFA. Results In external validation using US-based cohorts, the RAPID Community CSS achieved an AUC of 0.707, compared to the Spanish (AUC = 0.691) and Italian (AUC = 0.685) models, and the RAPID CD CSS demonstrated greater external sensitivity (0.836, threshold = 0.5) at the Youden-optimized threshold than the Spanish (0.605, threshold = 4) and Italian (0.735, threshold = 6) CSSs. Conclusions In US patient populations, the RAPID Community Cushing CSS demonstrated superior discriminative ability for CD compared to the Italian and Spanish CSSs, and the RAPID CD CSS achieved the highest sensitivity for CD among all CSSs evaluated.

  • Open Access

    Flexible In-Cavity MRI Receiving Coil for Ultrahigh Resolution Imaging of the Pituitary Gland

    by Siyuan Liu, Kunal S Patel, Sophie Peeters, Jiahao Lin, Aislyn C DiRisio, Harry Vinters, Robert Candler, Kyunghyun Sung, Marvin Bergsneider

    Purpose Preclinical design and construction of a flexible intra-sphenoid coil aiming for submillimeter resolution of the human pituitary gland.Methods Sphenoid sinus measurements determined coil design constraints for use in > 95% of adult patients. Temperature safety parameters were tested. The prototype 2-cm diameter coil was positioned in the sphenoid sinus of cadaveric human heads utilizing the transnasal endoscopic technique that is used clinically. Signal-to-noise ratio (SNR) was estimated comparing the prototype transnasal coil versus a standard clinical head coil. One cadaver pituitary gland was explanted and histologically examined for correlation to the imaging findings.Results With the coil positioned directly atop the sella turcica at 00 angle of the B0 static field, the craniocaudal distance (24 ± 4 mm) was the limiting constraint. Phantom experiments showed a negligible change in temperature at two sites over 15 minutes. The flexible coil was placed transnasally in cadaveric specimens using an endoscopic approach. The image quality was subjectively superior at higher spatial resolutions relative to the commercial 20-channel head coil. An average 17-fold increase in SNR was achieved within the pituitary gland. Subtle findings visualized only with the transnasal coil had potential pathological correlation with immunohistochemical analysis.Conclusions A transnasal radiofrequency coil feasibly provides a 17-fold boost in SNR at 3T, providing, in principle, equivalent imaging to a 51T scanner using a standard head coil. The ability to safely improve the quality of pituitary imaging may be helpful in the identification and subsequent surgical resection of small functional pituitary lesions.

  • Visual Outcomes After Pituitary Surgery

    by Benjamin Uy, Bayard Wilson, Wi Jin Kim, Giyarpuram Prashant, Marvin Bergsneider


  • Open Access

    Opposing CSF hydrodynamic trends found in the cerebral aqueduct and prepontine cistern following shunt treatment in patients with normal pressure hydrocephalus

    by Robert B. Hamilton, Fabien Scalzo, Kevin Baldwin, Amber Dorn, Paul Vespa, Xiao Hu, Marvin Bergsneider

    This study investigated cerebrospinal fluid (CSF) hydrodynamics using cine phase-contrast MRI in the cerebral aqueduct and the prepontine cistern between three distinct groups: pre-shunt normal pressure hydrocephalus (NPH) patients, post-shunt NPH patients, and controls. We hypothesized that the hyperdynamic flow of CSF through the cerebral aqueduct seen in NPH patients was due to a reduction in cisternal CSF volume buffering. Both hydrodynamic (velocity, flow, stroke volume) and peak flow latency (PFL) parameters were investigated. Scans were conducted on 30 pre-treatment patients ranging in age from 58 to 88 years along with an additional 12 controls. Twelve patients also received scans following either ventriculoatrial (VA) or ventriculoperitoneal (VP) shunt treatment (9 VP, 3 VA), ranging in age from 74 to 89 years with a mean follow up time of 6 months. Significant differences in area, velocity, flow, and stroke volume for the cerebral aqueduct were found between the pre-treatment NPH group and the healthy controls. Shunting caused a significant decrease in both caudal and cranial mean flow and stroke volume in the cerebral aqueduct. No significant changes were found in the prepontine cistern between the pre-treatment group and healthy controls. For the PFL, no significant differences were seen in the cerebral aqueduct between any of the three groups; however, the prepontine cistern PFL was significantly decreased in the pre-treatment NPH group when compared to the control group. Although several studies have quantified the changes in aqueductal flow between hydrocephalic groups and controls, few studies have investigated prepontine cistern flow. Our study was the first to investigate both regions in the same patients for NPH pre- and post- treatment. Following shunt treatment, the aqueductal CSF metrics decreased toward control values, while the prepontine cistern metrics trended up (not significantly) from the normal values established in this study. The opposing trend of the two locations suggests a redistribution of CSF pulsatility in NPH patients. Furthermore, the significantly decreased latency of the prepontine cisternal CSF flow suggests additional evidence for CSF pulsatility dysfunction.


  • Open Access

    Quality of Life before and after Endoscopic Pituitary Surgery as Measured by the SF-36

    by Edward C. Kuan, Frederick Yoo, Jennifer Chyu, Angela Oh, Wendy Huang, Marvin Bergsneider, Marilene Wang

    Objectives/Hypotheses: As utilization of endoscopic, transnasal techniques have gained prominence in the management of anterior skull base pathologies, assessing quality of life (QOL) after these approaches is an active area of investigation. Previous research has focused on sinonasal outcomes, but no studies have examined QOL as assessed by the oft-utilized 36-item short form (SF-36) instrument. Design: Retrospective review. Setting: Tertiary academic medical center. Participants: Patients who underwent endoscopic transnasal, transsphenoidal surgery for pituitary adenomas between January 1, 2007, and July 1, 2016, who completed preoperative and postoperative SF-36 surveys. Main Outcome Measures: SF-36 survey data as measured by its eight domains (physical functioning, physical role functioning, emotional role functioning, energy/fatigue, emotional well-being, social functioning, pain, general health). Results: There were 18 preoperative, 13 short-term (2 weeks or less after surgery) postoperative, and 14 long-term (> 2 weeks after surgery) postoperative surveys. There was no significant difference between preoperative and long-term postoperative SF-36 scores across all domains (p > 0.05). There was a trend toward decreased physical role functioning for the short-term postoperative group as compared with preoperative scores, but this was not significant (p = 0.06). Compared with standard U.S. general population summary data, these patients scored lower preoperatively in all domains except for emotional role functioning and pain (p < 0.05). Postoperatively, patients improved to baseline general population data scores with the exception of the physical role functioning domain (p < 0.0001). Conclusion: Patients undergoing endoscopic transnasal, transsphenoidal surgery for pituitary adenomas have lower QOL in 6 of 8 domains preoperatively, but improved to baseline values on the long run after surgery in 7 of 8 domains. This suggests that minimally invasive pituitary surgery has a restorative role in general QOL as measured by the SF-36.

  • Open Access

    Predicting the Probability of Diaphragmatic Descent with Very Large Pituitary Adenomas

    by Marvin Bergsneider, Wendy Huang, David McArthur, Anthony Heaney, Jeffrey D. Suh, Marilene B. Wang

    Transsphenoidal surgery has eclipsed open transcranial surgery as the preferred operative management of very large pituitary adenomas, although for some tumors with significant suprasellar components, craniotomy still may be considered. Surgical decision-making is typically predicated on which approach will best decompress the optic apparatus, which from an endonasal approach, translates into predicting the likelihood of diaphragmatic descent. In this study, we aimed to identify which pre-operative neuroimaging features predict failure of intra-operative diaphragmatic descent. A retrospective study was done of consecutive patients undergoing endoscopic endonasal surgery for pituitary adenomas 30 mm and larger by a single neurosurgeon at the UCLA Medical Center between May 2008 and April 2016 (n = 109). We correlated visualization of intra-operative diaphragmatic descent with pre-operative MRI findings as well as post hoc variables. The probability of diaphragma descent curve intersected the 50th-ile at 20 mm for suprasellar extension (p < 0.001) and 5 mm for anterior fossa (pre-tuberculum) extension (p = 0.004). A dumbbell ratio of > 1 (p = 0.043) and extradiaphragmatic (subarachnoid) extension were predictive (p < 0.001) as well. Apoplexy and maximum tumor size were not predictive (p > 0.05). Tumor firmness, a factor that could not be identified pre-operatively, was also associated with a lower diaphragma drop rate (p < 0.001). Intraoperative CSF leak did not have an effect (p > 0.05). Pituitary adenomas with suprasellar extension > 20 mm have a significantly lower probability of achieving chiasmal decompression via an endoscopic endonasal approach. The combination of anterior fossa extension, dumbbell shape, and subarachnoid involvement further decreases the probability. This assessment could be helpful in counseling patients pre-operatively on surgical expectations as well as surgical options.

  • Open Access

    Comparison of Male and Female Prolactinoma Patients Requiring Surgical Intervention

    by Frederick Yoo, Edward C. Kuan, Marvin Bergsneider, Marilene B. Wang

    Objectives/Hypotheses: Prolactinomas are the most common pituitary adenoma, comprising up to 50–60% of all functional pituitary tumors. Symptoms of a prolactinoma may stem from hormonal causes, with symptoms such as menstrual irregularities, galactorrhea or reduced libido, or may be the result of tumor mass effect, such as visual changes and chronic headache. Gender differences have been noted in prolactinomas, with males tending to present with larger tumors, and with more neurological sequelae from the mass effect of the tumor. However, no studies have investigated differences in surgical outcomes between males and females. The purpose of this study is to evaluate differences in patient characteristics, disease characteristics, and outcomes between male and female prolactinoma patients refractory to medical therapy. Study Design: Retrospective chart review Methods: The medical records of all patients with prolactinomas who underwent endoscopic endonasal skull base surgery at a tertiary medical center between January 1, 2013 and August 30, 2016 were included. Demographic information was collected, along with pathology and immunohistochemistry results, presenting symptoms, prolactin serum level at diagnosis, postoperative prolactin level, length of medical therapeutic trial, response to medical treatment, reason for proceeding to surgery, tumor size at time of surgery, presence of suprasellar extension, invasion of cavernous sinuses, complications, intraoperative and postoperative cerebrospinal fluid leak, type of resection, length of stay, and need for medical therapy postsurgery. Statistical analysis was performed using chi-squared test or student's t-test as applicable. Results: A total of 42 patients were identified, with 11 male and 31 female. The average age of males was 37.2 years and for females 35.4 years. Male patients were significantly more likely to report decreased libido (p < 0.0001) and visual changes (p = 0.0149) at presentation, whereas females were significantly more likely to report galactorrhea at presentation (p = 0.0029). Prolactin levels were on average higher in males than females, though this was not statistically significant (p = 0.1249). Females tended to have longer trials of medical therapy, though this was not statistically significant (p = 0.0814. Tumor size was on average larger in males, with this difference approaching significance (p = 0.0567). Males were significantly more likely to have suprasellar extension (p = 0.0238). Cavernous sinus invasion was seen more often in males but this difference was not significant (p = 0.0529). In terms of outcomes, males were significantly more likely to have a subtotal resection as opposed to a gross total resection (p = 0.0035) and require continued medical therapy post-operatively (p = 0.0196). Conclusions: Male prolactinoma patients tend to have larger tumors, with more aggressive symptoms and features. This may have a role in the differences in outcomes noted in this study group. As such, earlier identification and diagnosis in males may lead to improved outcomes.